We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Pacira BioSciences
PCRX
$1.04B
| $2.17M | 0.01% |
47,531
+1,771
| +4% | +$76.5K |
|
1502
Enviri
NVRI
$623M
| $2.16M | 0.01% |
169,624
+42,990
| +34% | +$574K |
|
|
VWR
1503
DELISTED
VWR Corporation
VWR
| $2.16M | 0.01% |
76,718
+4,422
| +6% | +$118K |
|
1504
SFL Corp
SFL
$1.64B
| $2.16M | 0.01% |
146,843
+74,806
| +104% | +$1.11M |
|
|
DNR
1505
DELISTED
Denbury Resources, Inc.
DNR
| $2.16M | 0.01% |
836,531
+96,024
| +13% | +$297K |
|
|
SNCR
1506
DELISTED
Synchronoss Technologies
SNCR
| $2.16M | 0.01% |
9,822
+2,583
| +36% | +$754K |
|
1507
Agios Pharmaceuticals
AGIO
$1.79B
| $2.15M | 0.01% |
36,908
+961
| +3% | +$46.1K |
|
|
VSTO
1508
DELISTED
Vista Outdoor Inc.
VSTO
| $2.15M | 0.01% |
104,567
-2,658
| -2% | -$65.7K |
|
1509
Eagle Bancorp
EGBN
$846M
| $2.15M | 0.01% |
36,052
+1,300
| +4% | +$78.9K |
|
1510
ATN International
ATNI
$366M
| $2.15M | 0.01% |
30,464
+8,156
| +37% | +$621K |
|
|
BRSL
1511
Brightstar Lottery PLC
BRSL
$1.84B
| $2.14M | 0.01% |
90,239
+6,360
| +8% | +$166K |
|
1512
City Holding Co
CHCO
$2.05B
| $2.13M | 0.01% |
33,067
+8,866
| +37% | +$580K |
|
|
CMO
1513
DELISTED
Capstead Mortgage Corp.
CMO
| $2.12M | 0.01% |
201,527
+52,426
| +35% | +$553K |
|
|
RAVN
1514
DELISTED
Raven Industries Inc
RAVN
| $2.12M | 0.01% |
73,067
+19,133
| +35% | +$519K |
|
|
IPHS
1515
DELISTED
Innophos Holdings, Inc.
IPHS
| $2.12M | 0.01% |
39,320
+10,360
| +36% | +$534K |
|
1516
Coca-Cola Consolidated
COKE
$12.5B
| $2.12M | 0.01% |
102,890
+36,370
| +55% | +$648K |
|
|
CALY
1517
Callaway Golf Company
CALY
$3.32B
| $2.12M | ﹤0.01% |
191,273
+53,430
| +39% | +$585K |
|
1518
Clearwater Paper
CLW
$339M
| $2.11M | ﹤0.01% |
37,701
+10,020
| +36% | +$593K |
|
1519
Global Net Lease
GNL
$1.84B
| $2.11M | ﹤0.01% |
87,477
+16,619
| +23% | +$394K |
|
1520
Mueller Water Products
MWA
$3.95B
| $2.11M | ﹤0.01% |
178,166
+5,897
| +3% | +$74.9K |
|
|
ZNGA
1521
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $2.1M | ﹤0.01% |
737,372
+52,307
| +8% | +$141K |
|
1522
Patrick Industries
PATK
$2.74B
| $2.1M | ﹤0.01% |
66,557
+20,902
| +46% | +$723K |
|
1523
Piper Sandler
PIPR
$5.12B
| $2.09M | ﹤0.01% |
130,860
+31,872
| +32% | +$564K |
|
|
ECOL
1524
DELISTED
US Ecology, Inc.
ECOL
| $2.08M | ﹤0.01% |
44,466
+11,684
| +36% | +$584K |
|
|
CIR
1525
DELISTED
CIRCOR International, Inc
CIR
| $2.08M | ﹤0.01% |
34,944
+8,089
| +30% | +$497K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.